Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study-Reference-Cited by-同舟云学术

Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study

Published:2019-04 Issue:4 Volume:80 Page:1022-1028
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

van Delft Lieke C.J.,Nelemans Patty J.,Jansen Maud H.E.,Arits Aimee H.M.M.,Roozeboom Marieke H.,Hamid Myrurgia A.,Mosterd Klara,Kelleners-Smeets Nicole W.J.

Funder

ZonMW

Publisher

Elsevier BV

Subject

Dermatology

Reference39 articles.

1. Basal cell carcinoma: an evidence-based treatment update;Clark;Am J Clin Dermatol,2014

2. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial;Williams;J Invest Dermatol,2017

3. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen’s disease, basal cell carcinoma;Morton;J Eur Acad Dermatol Venereol,2013

4. Update of the European guidelines for basal cell carcinoma management;Trakatelli;Eur J Dermatol,2014

5. Guidelines of care for the management of basal cell carcinoma;Kim;J Am Acad Dermatol,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy assessment of oxygen flow assisted administration of topical methotrexate (OFA‐MTX5%) for superficial basal cell carcinoma assessed by optical coherence tomography;JEADV Clinical Practice;2023-01-17

2. Role of Photodynamic Therapy in Oncodermatology;Interdisciplinary Cancer Research;2023

3. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study;Journal of the American Academy of Dermatology;2022-06

4. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma;Dermatology;2022

5. Basal Cell Carcinoma;Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients;2022